15502
1-Boc-哌嗪
≥98.0% (GC)
别名:
哌嗪-1-甲酸叔丁酯
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C9H18N2O2
化学文摘社编号:
分子量:
186.25
NACRES:
NA.22
PubChem Substance ID:
eCl@ss:
32160406
UNSPSC Code:
12352100
MDL number:
Beilstein/REAXYS Number:
879985
产品名称
1-Boc-哌嗪, ≥98.0% (GC)
InChI
1S/C9H18N2O2/c1-9(2,3)13-8(12)11-6-4-10-5-7-11/h10H,4-7H2,1-3H3
SMILES string
CC(C)(C)OC(=O)N1CCNCC1
InChI key
CWXPZXBSDSIRCS-UHFFFAOYSA-N
assay
≥98.0% (GC)
form
solid
mp
43-47 °C (lit.)
43-47 °C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
1-Boc-哌嗪与各种芳基卤化物发生 Buchwald-Hartwig 胺化反应，形成相应的的胺衍生物。它可用于合成许多生物活性分子的单取代哌嗪中间体和含有哌嗪的原料药，如曲唑酮。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
235.4 °F - closed cup
flash_point_c
113 °C - closed cup
ppe
dust mask type N95 (US), Eyeshields, Gloves
Design and synthesis of new potent N, N-bis (arylalkyl) piperazine derivatives as multidrug resistance (MDR) reversing agents.
Dei S, et al.
European Journal of Medicinal Chemistry, 147, 7-20 (2018)
Synthesis and biological evaluation of new 2-(6-alkyl-pyrazin-2-yl)-1H-benz [d] imidazoles as potent anti-inflammatory and antioxidant agents.
Shankar B, et al.
Medicinal Chemistry Research, 26(9), 1835-1846 (2017)
Synthesis and dual D2 and 5-HT1A receptor binding affinities of 5-piperidinyl and 5-piperazinyl-1 H-benzo [d] imidazol-2 (3 H)-ones.
Ullah N
Journal of Enzyme Inhibition and Medicinal Chemistry, 29(2), 281-291 (2014)
Conformationally rigid derivatives of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin-1a receptors.
Jorgensen WT, et al.
European Journal of Medicinal Chemistry, 143, 1644-1656 (2018)
Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl) phenyl] piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
Bang-Andersen B, et al.
Journal of Medicinal Chemistry, 54(9), 3206-3221 (2011)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持